Skip to main content
CUTISDERMA CARE
Menu
Cutis Anti Acne Cream by CUTIS, photographed in a styled setting

Acne / For professional product reference

Cutis Anti Acne Cream

NDGA & Oleanolic Acid

Cutis Anti Acne Cream is positioned in CUTIS product information “For Clearer Looking Skin,” with NDGA and Oleanolic Acid.

Portfolio presentation only. Products are not sold through this website.

Cutis Anti Acne Cream original CUTIS packaging and promotional artwork
Original CUTIS product artwork. Printed statements are product positioning, not independent clinical evidence.

01 / Formulation

What’s in it

Actives and functions described in CUTIS product information. Ingredient functions below reflect CUTIS product information.

NDGA — Nordihydroguaiaretic Acid
CUTIS describes control of sebum overproduction by regulating the sebaceous gland, downregulation of excess skin-cell production and reduction of inflammation.
Oleanolic Acid
CUTIS describes sebum-production control support, antioxidant support and anti-inflammatory support.

02 / CUTIS product directions

How to use

  1. 01Cleanse with a gentle, non-drying cleanser.
  2. 02Apply a small quantity (pea size).
  3. 03Spread gently over affected/acne-prone areas with light circular motions until absorbed.
  4. 04Use sunscreen during the day.

03 / Product positioning

What CUTIS says about it

  • — “For Clearer Looking Skin.”
  • — “The power of duo control the Acne Breakouts on regular use.”

The acne cascade described in CUTIS product information:

Stage 1 — Clogged pores: overproduction of sebum.

Stage 2 — Whiteheads & blackheads: overactivity of cells lining the pore, associated in CUTIS product information with hormonal changes and local deficiency of linoleic acid.

Stage 3 — Papules & pustules: clogged pores lead to bacterial growth.

Stage 4 — Deep nodules: repeated bacterial surge leads to inflammation and deep nodules.

04 / Independent evidence

Evidence context

The AAD acne guideline supports treatments such as topical retinoids and benzoyl peroxide, with other clinician-directed options according to severity. NDGA and Oleanolic Acid are not established guideline first-line acne treatments. CUTIS ingredient functions and clearer-looking-skin positioning are not evidence that this cream cures acne.

05 / Important notes

A responsible reference

  • CUTIS’s cascade is a simplified educational model—not the only accepted account of acne biology. Comedones and inflammatory lesions can coexist.
  • No CUTIS-specific clinical trial or ingredient concentrations are presented.
  • Painful nodules, scarring or persistent acne warrant dermatological evaluation.

Independent sources

For general and professional reference only. Product positioning is not a diagnosis, a guarantee of results or a substitute for individualized medical advice.

← Back to portfolio